Calls for Drug Companies to Share Vaccine Formulas Grow as Global COVID Crisis Worsens

“We’ve been sold a bill of goods that somehow if we prioritize ourselves, we’ll be safe,” Professor Brook Baker ’76, senior policy analyst for Health GAP (Global Access Project), tells CBS News. “It’s in fact not true. We have to prioritize everyone, everywhere and not let intellectual property stand in the way of achieving that.”